Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer Joins Accelrys Crystallography Consortium

SAN FRANCISCO, Nov. 13 – Pfizer joined Accelrys’ High Throughput Crystallography Consortium, Accelrys announced Tuesday.

Princeton, N.J.-based Accelrys, a subsidiary of Pharmacopeia, created the consortium to explore and validate rapid methods for X-ray structure determination, model building, and structure validation, according to the company.  The agreement with Pfizer covers a number of sites, including Sandwich, UK, Groton, Ann Arbor and La Jolla.

With Pfizer, the consortium’s total membership is 13 companies, including Bristol-Myers Squibb, Genencor, and the Genetics Institute.  

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.